Atlas Trials

Efficacy, Safety and Tolerability of Tideglusib to Treat Mild-to-Moderate Alzheimer's Disease Patients

Clinical trial NCT01350362 · COMPLETED

Trial details

NCT number
NCT01350362
Sponsor
Noscira SA
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2011-04-01
Primary completion
2012-07-01
Enrollment
306

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.